Affordable Access

deepdyve-link
Publisher Website

Surgical outcome after neoadjuvant chemotherapy and bevacizumab: results from the GeparQuinto study (GBG 44).

Authors
  • Gerber, Bernd
  • von Minckwitz, Gunter
  • Eidtmann, Holger
  • Rezai, Mahdi
  • Fasching, Peter
  • Tesch, Hans
  • Eggemann, Holm
  • Schrader, Iris
  • Kittel, Kornelia
  • Hanusch, Claus
  • Solbach, Christine
  • Jackisch, Christian
  • Kunz, Georg
  • Blohmer, Jens-Uwe
  • Huober, Jens
  • Hauschild, Maik
  • Nekljudova, Valentina
  • Loibl, Sibylle
  • Untch, Michael
Type
Published Article
Journal
Annals of Surgical Oncology
Publisher
Springer - Society of Surgical Oncology
Publication Date
Aug 01, 2014
Volume
21
Issue
8
Pages
2517–2524
Identifiers
DOI: 10.1245/s10434-014-3606-9
PMID: 24740826
Source
Medline
License
Unknown

Abstract

Addition of bevacizumab to neoadjuvant chemotherapy might be associated with an increased risk for surgical complications in patients treated with BCS or after repeated surgeries.

Report this publication

Statistics

Seen <100 times